These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17890877)

  • 21. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis.
    Rosenlöf K; Kivivuori SM; Grönhagen-Riska C; Teppo AM; Slimes MA
    Clin Nephrol; 1995 Apr; 43(4):249-55. PubMed ID: 7606879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease.
    Bodolay E; Aleksza M; Antal-Szalmás P; Végh J; Szodoray P; Soltész P; Szegedi A; Szekanecz Z
    J Rheumatol; 2002 Oct; 29(10):2136-42. PubMed ID: 12375323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women.
    Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H
    Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients.
    Tarng DC; Hung SC; Huang TP
    J Am Soc Nephrol; 2004 Sep; 15(9):2486-93. PubMed ID: 15339999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T lymphocyte subsets and NK cell cytotoxicity in chronic hemodialysis patients. The effect of recombinant human erythropoietin (rHu-EPO) treatment.
    Baj Z; Pokoca L; Majewska E; Luciak M; Tchórzewski H
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):201-6. PubMed ID: 1300984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome.
    Cetiner S; Demirhan O; Inal TC; Tastemir D; Sertdemir Y
    Int J Immunogenet; 2010 Aug; 37(4):233-7. PubMed ID: 20477881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies.
    Borges A; Borges M; Fernandes J; Nascimento H; Sameiro-Faria M; Miranda V; Reis F; Belo L; Costa E; Santos-Silva A
    Ren Fail; 2011; 33(2):138-43. PubMed ID: 21332334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of intravenous iron therapy for HCV-positive haemodialysis patients.
    Kahraman S; Yilmaz R; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Nephron Clin Pract; 2005; 100(3):c78-85. PubMed ID: 15824511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients.
    Abe M; Okada K; Soma M; Matsumoto K
    Clin Nephrol; 2011 Jan; 75(1):49-58. PubMed ID: 21176750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of interleukin-10 in serum and erythropoietin sensitivity in ESRD patients on hemodialysis.
    Attia FM; Tawfik GA; Kalil KA; Mossalam MF
    Int J Lab Hematol; 2010 Oct; 32(5):524-9. PubMed ID: 20148986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal cytokine synthesis as a consequence of increased intracellular oxidative stress in children treated with dialysis.
    Zachwieja J; Zaniew M; Runowski D; Lewandowska-Stachowiak M; Stefaniak E; Siwińska A
    Nephron Clin Pract; 2005; 101(2):c100-8. PubMed ID: 15956803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients.
    Shaheen FA; Souqiyyeh MZ; Akeel N
    Saudi J Kidney Dis Transpl; 2002; 13(2):131-40. PubMed ID: 17660651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of recombinant human erythropoietin administration on immunological indices in patients undergoing chronic hemodialysis.
    Yorioka N; Hamaguchi N; Takasugi N; Shigemoto K; Harada S; Fujiwara K; Ishida A; Maeda T; Kawai A; Yamakido M
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):981-8. PubMed ID: 8255010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.